"QuantityPath","Parameter","PKParameter","Value"
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Lipophilicity","C_max",-0.255050651858062
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Specific intestinal permeability (transcellular)","C_max",0.272644760221021
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A9-Kassahun 2007-In vitro Vmax for liver microsomes","C_max",-0.0877241239685241
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A1-Kassahun 2007-In vitro Vmax for liver microsomes","C_max",-0.265017344244322
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Iwamoto 2008 10mg PO (Figure 2) Safety-Tolerability-PK study-Weibull (lactose formulation)-Dissolution shape","C_max",0.717806121207493
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Lipophilicity","t_max",0
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Specific intestinal permeability (transcellular)","t_max",-0.166666666666667
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A9-Kassahun 2007-In vitro Vmax for liver microsomes","t_max",0
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A1-Kassahun 2007-In vitro Vmax for liver microsomes","t_max",0
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Iwamoto 2008 10mg PO (Figure 2) Safety-Tolerability-PK study-Weibull (lactose formulation)-Dissolution shape","t_max",0
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Lipophilicity","C_tEnd",-0.658036070363549
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Specific intestinal permeability (transcellular)","C_tEnd",-0.142105019575402
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A9-Kassahun 2007-In vitro Vmax for liver microsomes","C_tEnd",-0.464354625264064
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A1-Kassahun 2007-In vitro Vmax for liver microsomes","C_tEnd",-0.666248721331105
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Iwamoto 2008 10mg PO (Figure 2) Safety-Tolerability-PK study-Weibull (lactose formulation)-Dissolution shape","C_tEnd",0.239491668949846
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Lipophilicity","AUC_tEnd",-0.365981942542092
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Specific intestinal permeability (transcellular)","AUC_tEnd",0.145308734277524
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A9-Kassahun 2007-In vitro Vmax for liver microsomes","AUC_tEnd",-0.248584988847848
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A1-Kassahun 2007-In vitro Vmax for liver microsomes","AUC_tEnd",-0.456213009378286
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Iwamoto 2008 10mg PO (Figure 2) Safety-Tolerability-PK study-Weibull (lactose formulation)-Dissolution shape","AUC_tEnd",0.635222591621664
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Lipophilicity","AUC_inf",-0.400491060705077
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Specific intestinal permeability (transcellular)","AUC_inf",0.129566148035951
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A9-Kassahun 2007-In vitro Vmax for liver microsomes","AUC_inf",-0.254324709717523
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A1-Kassahun 2007-In vitro Vmax for liver microsomes","AUC_inf",-0.457988043729724
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Iwamoto 2008 10mg PO (Figure 2) Safety-Tolerability-PK study-Weibull (lactose formulation)-Dissolution shape","AUC_inf",0.594353225491899
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Lipophilicity","MRT",-0.24659864802962
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Specific intestinal permeability (transcellular)","MRT",-0.16377201523516
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A9-Kassahun 2007-In vitro Vmax for liver microsomes","MRT",-0.10491261965057
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A1-Kassahun 2007-In vitro Vmax for liver microsomes","MRT",-0.0923222742226498
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Iwamoto 2008 10mg PO (Figure 2) Safety-Tolerability-PK study-Weibull (lactose formulation)-Dissolution shape","MRT",-0.297333992078407
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Lipophilicity","Thalf",-0.359039973614929
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Specific intestinal permeability (transcellular)","Thalf",-0.00931248072596709
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A9-Kassahun 2007-In vitro Vmax for liver microsomes","Thalf",0.107547194130446
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A1-Kassahun 2007-In vitro Vmax for liver microsomes","Thalf",0.176240934773225
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Iwamoto 2008 10mg PO (Figure 2) Safety-Tolerability-PK study-Weibull (lactose formulation)-Dissolution shape","Thalf",-0.377071796097466
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Lipophilicity","FractionAucLastToInf",-0.616549378031806
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Specific intestinal permeability (transcellular)","FractionAucLastToInf",-0.281606842240119
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A9-Kassahun 2007-In vitro Vmax for liver microsomes","FractionAucLastToInf",-0.102404012562982
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A1-Kassahun 2007-In vitro Vmax for liver microsomes","FractionAucLastToInf",-0.0313675251015214
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Iwamoto 2008 10mg PO (Figure 2) Safety-Tolerability-PK study-Weibull (lactose formulation)-Dissolution shape","FractionAucLastToInf",-0.731370208178693
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Lipophilicity","CL",0.400617661705911
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Specific intestinal permeability (transcellular)","CL",-0.129682783268624
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A9-Kassahun 2007-In vitro Vmax for liver microsomes","CL",0.254350613498688
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A1-Kassahun 2007-In vitro Vmax for liver microsomes","CL",0.45770197269789
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Iwamoto 2008 10mg PO (Figure 2) Safety-Tolerability-PK study-Weibull (lactose formulation)-Dissolution shape","CL",-0.600509267137191
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Lipophilicity","Vss",0.153756813915462
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Specific intestinal permeability (transcellular)","Vss",-0.293718460393379
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A9-Kassahun 2007-In vitro Vmax for liver microsomes","Vss",0.149434923752102
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A1-Kassahun 2007-In vitro Vmax for liver microsomes","Vss",0.365535800610767
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Iwamoto 2008 10mg PO (Figure 2) Safety-Tolerability-PK study-Weibull (lactose formulation)-Dissolution shape","Vss",-0.899171823472165
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Lipophilicity","Vd",0.0413012817467603
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-Specific intestinal permeability (transcellular)","Vd",-0.139068624744658
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A9-Kassahun 2007-In vitro Vmax for liver microsomes","Vd",0.361957106485256
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Raltegravir-UGT1A1-Kassahun 2007-In vitro Vmax for liver microsomes","Vd",0.634043164423855
"Organism|PeripheralVenousBlood|Raltegravir|Plasma (Peripheral Venous Blood)","Iwamoto 2008 10mg PO (Figure 2) Safety-Tolerability-PK study-Weibull (lactose formulation)-Dissolution shape","Vd",-0.979031040920114
